fulvestrant has been researched along with lignans in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, CW; Liu, YC; Lo, YC; Wu, SN | 1 |
| Cong, H; Li, D; Liu, J; Lu, Y; Tian, W; Wei, A; Yang, L; Zhuo, Y | 1 |
2 other study(ies) available for fulvestrant and lignans
| Article | Year |
|---|---|
Inhibitory action of ICI-182,780, an estrogen receptor antagonist, on BK(Ca) channel activity in cultured endothelial cells of human coronary artery.
Topics: 2-Methoxyestradiol; Biphenyl Compounds; Cell Division; Cells, Cultured; Coronary Vessels; Drug Interactions; Endothelium, Vascular; Estradiol; Fulvestrant; Humans; Kinetics; Lignans; Masoprocol; Membrane Potentials; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Receptors, Estrogen | 2003 |
Syringaresinol attenuates sepsis-induced cardiac dysfunction by inhibiting inflammation and pyroptosis in mice.
Topics: Animals; Cardiotonic Agents; Cinnamates; Disease Models, Animal; Fulvestrant; Furans; Heart; Heart Diseases; Humans; Indoles; Inflammation; Lignans; Male; Mice; Molecular Docking Simulation; Myocardium; Pyroptosis; Receptors, Estrogen; Sepsis; Sirtuin 1 | 2021 |